← Open Payments lookup

ROBIN MILLER: Open Payments

NPI 1801453014 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,189 in 55 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $521 · 2025 $1,189

Food & beverage: $1,189
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.20$379
Madrigal Pharmaceuticals6$262
Ardelyx, Inc.12$192
Janssen Biotech, Inc.4$88
Phathom Pharmaceuticals, Inc.3$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$45
Janssen Pharmaceuticals, Inc2$41
Regeneron Healthcare Solutions, Inc.1$32
Braintree Laboratories, Inc.1$29
ABBVIE INC.2$28

Products named: ENTYVIO, REZDIFFRA, IBSRELA, TREMFYA, EOHILIA, VOQUEZNA, XIFAXAN, DUPIXENT.

Industry payments across CA — which companies pay providers there.